microbio 303 - unit #4

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/227

encourage image

There's no tags or description

Looks like no tags are added yet.

228 Terms

1
New cards
Goal of clinical diagnostics
To identify the pathogen causing an infection and determine appropriate treatment.
2
New cards
Culture-dependent methods
Methods that require growing or culturing the microorganism before identification.
3
New cards
Culture-independent methods
Methods that identify pathogens without requiring the microorganism to be grown in culture.
4
New cards
Examples of culture-based identification
Culturing microorganisms on selective or differential media and examining their physiological properties.
5
New cards
Examples of culture-independent identification
Molecular testing, qPCR, qRT-PCR, sequencing, serology, and immunoassays.
6
New cards
Five major diagnostic approaches
Culture, biochemical tests, microscopy, molecular testing, and rapid tests/immunoassays.
7
New cards
Culture-based identification
Best for bacterial pathogens; also used for fungi, but not good for viruses.
8
New cards
Culture-based identification: characteristics examined
Antibiotic sensitivities, biochemical properties, Gram reaction, and cell shape.
9
New cards



10
New cards
Differential media
Media that distinguish microorganisms based on observable differences in their growth or biochemical properties.
11
New cards
Dichotomous key
A tool that minimizes the number of biochemical tests and resources needed to identify an organism based on physiological characteristics.
12
New cards
Microscopy
Useful for identifying pathogens with unusual morphology and determining Gram reaction.
13
New cards
Microscopy used for bacteria, fungi, and protozoa
Light microscopy.
14
New cards
Microscopy used for viruses
Electron microscopy.
15
New cards
Culture used for bacteria and fungi
Used to purify and amplify microorganisms.
16
New cards
Culture used for viruses
Used to examine cytopathology.
17
New cards
Biochemical tests
Used for identification and antibiotic sensitivity testing of bacteria and fungi.
18
New cards
Molecular testing
Used for bacteria, fungi, protozoa, and viruses; includes nucleic acid amplification, sequencing, and fingerprinting.
19
New cards
Rapid tests and immunoassays
Used for rapid pathogen identification; include biochemical identification and immunoassays.
20
New cards
Examples of immunoassays used across pathogen types
ELISA, multiplex microbead systems, and complement fixation.
21
New cards
Why culture-based methods are not good for viruses
Viruses are not identified by growing them on the same types of media used for bacteria and fungi; viral culture examines cytopathology.
22
New cards
Why different diagnostic methods are needed
Different pathogen types require different identification approaches; the same tests are not appropriate for every pathogen.
23
New cards
Symptoms and body location in diagnosis
Symptoms and the location where a microorganism is found can help identify the likely pathogen.
24
New cards
Staphylococcus aureus carriage
Approximately 30% of the population asymptomatically carries S. aureus as part of the skin microbiome.
25
New cards
Staphylococcus aureus as a pathogen
An opportunistic pathogen that commonly causes disease when host defenses are compromised.
26
New cards
Streptococcus mutans location
Found in most adult oral microbiomes.
27
New cards
Streptococcus mutans disease
A major cause of dental caries and an opportunistic pathogen.
28
New cards
Streptococcus pyogenes
Usually causes disease even in otherwise healthy people; it is a primary pathogen.
29
New cards
Asymptomatic carriage of Streptococcus pyogenes
Some people can carry it asymptomatically and transiently.
30
New cards
Streptococcus pneumoniae location
Can colonize the upper respiratory tract (URT) asymptomatically.
31
New cards
Streptococcus pneumoniae as a pathogen
An opportunistic pathogen.
32
New cards



33
New cards
Staphylococcus catalase test
Catalase positive.
34
New cards
Staphylococcus coagulase test
Coagulase-positive strains are associated with pathogenicity; coagulase-negative strains are described in the lecture as nonpathogenic.
35
New cards
Staphylococcus virulence factors
Many virulence factors are present, and many are carried on plasmids.
36
New cards
Pyogenic
Pus-producing.
37
New cards
Staphylococcus biofilms
Staphylococcus can form biofilms.
38
New cards
Staphylococcus aureus coagulase result
Coagulase positive.
39
New cards
Staphylococcus aureus disease range
Can produce disease in nearly every organ and tissue of the body.
40
New cards
Staphylococcus aureus and host defenses
It mostly causes disease where host defenses have been compromised.
41
New cards
Staphylococcal diseases
Caused by a number of virulence factors.
42
New cards
Staphylococcal superantigens
Many toxins produced by Staphylococcus are superantigens that are resistant to heat and acid.
43
New cards
Staphylococcal food poisoning
Ingestion of a toxin can cause intoxication within minutes to hours, even if the organism has been killed or removed.
44
New cards
Staphylococcus aureus virulence factors: enzymes and proteins
β-lactamase, catalase, coagulase, DNase, Protein A, proteases, lipases, hyaluronidase, and nuclease.
45
New cards
Staphylococcus aureus virulence factors: toxins
Enterotoxins, exfoliative toxins A and B, hemolysins, Panton-Valentine leukocidin, and toxic shock syndrome toxin-1.
46
New cards
Exfoliative toxins A and B
Superantigens produced by Staphylococcus.
47
New cards
Toxic shock syndrome toxin-1
A Staphylococcal superantigen.
48
New cards
Diseases associated with Staphylococcus aureus
Pneumonia, infective endocarditis, sepsis, osteomyelitis, menstrual toxic shock syndrome, and soft tissue infections.
49
New cards
Staphylococcus aureus transmission
Skin contact, respiratory transmission, and fomites.
50
New cards
Fomites
Objects or surfaces that can carry and transmit infectious agents.
51
New cards
MRSA
Methicillin-resistant Staphylococcus aureus.
52
New cards
MRSA epidemiology in the lecture
More than 80,000 infections and 11,000 deaths per year in the United States (figures shown in the lecture).
53
New cards
Large pimple-type infections and MRSA
The lecture describes large pimple-type infections as being treated as MRSA until proven otherwise, with incision, drainage, and antibiotics.
54
New cards
MRSA setting of infection
Predominantly nosocomial, but there is also a large pool in livestock populations.
55
New cards
Nosocomial
Associated with a healthcare setting or hospital.
56
New cards
Antibiotic resistance plasmids
A single plasmid can carry genes that provide resistance to multiple antibiotics and other substances.
57
New cards
Resistance genes shown on the Staphylococcus plasmid
Trimethoprim resistance, penicillin-family resistance, vancomycin resistance, disinfectant resistance, and streptomycin-family resistance.
58
New cards
Other genes shown on the Staphylococcus plasmid
Genes that help the plasmid spread.
59
New cards
qPCR
A culture-independent molecular diagnostic method used in the lecture to detect pathogen nucleic acid.
60
New cards
qRT-PCR
A culture-independent molecular diagnostic method listed alongside qPCR; it is used when RNA is the target.
61
New cards
qPCR and qRT-PCR
Examples of culture-independent methods shown in the lecture.
62
New cards
Serology
An approach to identifying infection using antibodies in a patient's blood serum.
63
New cards
Antibodies
Proteins made by the body that recognize antigens.
64
New cards
Antigens
Substances recognized as foreign by the body.
65
New cards
Antibody-antigen recognition
Antibodies recognize specific antigens; different antigens are recognized by different antibodies.
66
New cards
Immunoassays
Diagnostic tests that use antibody-antigen recognition.
67
New cards
Agglutination
Antibodies crosslink antigenic particles to form visible clumps.
68
New cards
Positive agglutination result
Visible clumping indicates antibody-antigen binding.
69
New cards
Negative agglutination control
No visible clumps.
70
New cards
Staphylococcus aureus agglutination test
Uses beads coated with an antibody that recognizes Protein A, a surface antigen on S. aureus.
71
New cards
Protein A
A surface antigen on Staphylococcus aureus that can be recognized in an agglutination test.
72
New cards
Immunofluorescence
An immunoassay that uses fluorescently labeled antibodies to detect antigens or antibodies.
73
New cards
Direct immunofluorescence
Fixes a specimen to a slide and stains it with antibody-linked fluorophores to detect an antigen in the specimen.
74
New cards
Indirect immunofluorescence
Detects antibodies in a patient's blood serum after exposure to a pathogen.
75
New cards
Indirect immunofluorescence: components
Known antigen, patient serum containing possible antibodies, and a fluorescently labeled secondary antibody.
76
New cards
Positive indirect immunofluorescence
Fluorescence is detected, indicating antibodies in the patient's serum recognize the known antigen.
77
New cards
Negative indirect immunofluorescence
No fluorescence is detected because the patient's serum does not contain the antibody being tested for.
78
New cards
Direct versus indirect immunofluorescence
Direct detects antigen in a specimen using a fluorescently labeled antibody; indirect detects antibodies in patient serum using a known antigen and fluorescent secondary antibody.
79
New cards
ELISA
Enzyme-linked immunosorbent assay; an immunoassay that uses enzyme-linked antibodies.
80
New cards
Direct ELISA
An enzyme-linked antibody binds directly to an antigen.
81
New cards
Indirect ELISA
An enzyme-linked antibody binds to another antibody.
82
New cards
MRSA identification: Gram stain and culture
Look for Gram-positive cocci in clusters and culture the specimen aerobically.
83
New cards
MRSA identification: biochemical tests
Look for catalase-positive and coagulase-positive results consistent with S. aureus.
84
New cards
MRSA identification: Chromeagar
Culture the specimen on Chromeagar containing penicillin; the medium distinguishes S. aureus from close relatives by color.
85
New cards
MRSA identification: qPCR
Amplify the mecA gene, which is associated with methicillin resistance, and the nuc gene, which encodes a nuclease unique to S. aureus.
86
New cards
mecA gene
Associated with methicillin resistance; can be targeted by qPCR when identifying MRSA.
87
New cards
nuc gene
Encodes a nuclease unique to Staphylococcus aureus; can be targeted by qPCR to identify S. aureus.
88
New cards
MRSA identification: agglutination
Look for agglutination when cells are mixed with beads coated in an antibody that recognizes Protein A.
89
New cards
Four approaches to identifying MRSA
Symptoms and clinical presentation, culture and biochemical tests, qPCR for mecA and nuc, and Protein A agglutination.
90
New cards
Next-generation sequencing in clinical diagnostics
A culture-independent method shown for identifying pathogens, including in clinical metagenomic testing.
91
New cards
Biosafety levels (BSL)
Containment levels used when working with pathogens; different levels are required because pathogens differ in risk.
92
New cards
Why different biosafety levels are required
To provide appropriate containment and precautions based on the risk posed by the pathogen.
93
New cards
Highest biosafety level
BSL-4.
94
New cards
BSL-1
Low-risk organisms that are not known to consistently cause disease in healthy adults.
95
New cards
Examples of BSL-1 organisms
Lactobacillus and Vibrio fischeri.
96
New cards
BSL-2
Organisms associated with human disease but not transmitted by aerosols, according to the lecture.
97
New cards
Examples of BSL-2 organisms
Salmonella, E. coli O157:H7, and Staphylococcus aureus.
98
New cards
BSL-3
Organisms with potential for aerosol transmission and serious or lethal consequences.
99
New cards
Examples of BSL-3 organisms
Clostridium botulinum and Mycobacterium tuberculosis.
100
New cards
BSL-4
Life-threatening agents that are unknown or aerosol-transmitted, representing the highest risk level.